Inositol(myo)-1(or 4)-Monophosphatase 1 (IMPA1) Peptide
Quick Overview for Inositol(myo)-1(or 4)-Monophosphatase 1 (IMPA1) Peptide (ABIN939595)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- IVTEAGGVLM DVTGGPFDLM SRRVIAANNR ILAERIAKEI QVIPLQRDDE
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of IMPA1 antibody,
Alternative Names: IMPA1 control peptide, IMPA1 antibody Blocking Peptide, Anti-IMPA1 Blocking Peptide, Inositol Blocking Peptide, Myo-1 Blocking Peptide, IMPA Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- IMPA1 (Inositol(myo)-1(or 4)-Monophosphatase 1 (IMPA1))
-
Background
- IMPA1 is responsible for the provision of inositol required for synthesis of phosphatidylinositol and polyphosphoinositides and has been implicated as the pharmacological target for lithium action in brain. IMPA1 can use myo-inositol monophosphates, myo-inositol-1,3-diphosphate, myo-inositol-1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates.
-
Molecular Weight
- 30 kDa
Target
-